product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
more the resources, R&D and equipment to enhance capability in production and product development. Furthermore, ESPBG’s Sales improved 7.0% over the same quarter of last year, mainly contributed by sales
started resulting the Company has to realize the cost including the depreciation of factory, machinery and other system; however, the manufacturing capacity has not utilize in its full capacity and the
Institutions Development Fund; (q) juristic persons in which any persons specified under sub clause (a) to (p) hold shares in an aggregate of more than 75% of the total number of voting shares; (r) foreign
Development Fund; (q) juristic persons in which any persons specified under sub clause (a) to (p) hold shares in an aggregate of more than 75% of the total number of voting shares; (r) foreign investors having
2.47 million baht or 2.65% from sale revenue of last year, increased by 0.99 million baht or 40.08% increased, which is a result from higher Research and Development expenses in preparing product samples
that the company has a rising sale trend, so it has to order more raw material and there is a part of creditor to improve product system and machine purchase amount of Baht 15.54 million, and decrease in
investing in product development to serve needs of target customers and change in product mix strategy to get high quality product which is value for money to serve customer. The company focused on marketing
development the Company focuses on how to serve needs of target customers and change in product mix strategy to get high quality product which is value for money to serve customer with marketing strategy to